SARS-CoV-2, the causative agent of COVID-19, first emerged
in 2019. Antibody responses against SARS-CoV-2 have been
given a lot of attention. However, the armamentarium of humoral
and T cells may have differing roles in different viral
infections. Though the exact role of T cells in COVID-19 remains
to be elucidated, prior experience with human coronavirus
has revealed an essential role of T cells in the outcomes
of viral infections. Moreover, an increasing body of evidence
suggests that T cells might be effective against SARS-CoV-2.
This review summarizes the role of T cells in mouse CoV,
human pathogenic respiratory CoV in general and SARSCoV-
2 in specific.
Citations
Citations to this article as recorded by
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions Kuei-Ching Hsiung, Huan-Jung Chiang, Sebastian Reinig, Shin-Ru Shih Vaccines.2024; 12(12): 1345. CrossRef
Safety and efficacy of COVID-19 vaccine immunization during pregnancy in 1024 pregnant women infected with the SARS-CoV-2 Omicron virus in Shanghai, China Hongmei Deng, Yinpeng Jin, Minmin Sheng, Min Liu, Jie Shen, Wei Qian, Gang Zou, Yixin Liao, Tiefu Liu, Yun Ling, Xiaohong Fan Frontiers in Immunology.2024;[Epub] CrossRef
Differential Impact of Spike Protein Mutations on SARS-CoV-2 Infectivity and Immune Evasion: Insights from Delta and Kappa Variants Tae-Hun Kim, Sojung Bae, Jinjong Myoung Journal of Microbiology and Biotechnology.2024; 34(12): 2506. CrossRef
Animal models for COVID-19 and tuberculosis Björn Corleis, Max Bastian, Donata Hoffmann, Martin Beer, Anca Dorhoi Frontiers in Immunology.2023;[Epub] CrossRef
A mathematical model and simulation scenarios for T and B cells immune response to severe acute respiratory syndrome-coronavirus-2 L Cuesta-Herrera, F Córdova-Lepe, L Pastenes, A D Arencibia, Y Baldera-Moreno, H A Torres-Mantilla Journal of Physics: Conference Series.2023; 2516(1): 012007. CrossRef
Distinctive Combinations of RBD Mutations Contribute to Antibody Evasion in the Case of the SARS-CoV-2 Beta Variant Tae-Hun Kim, Sojung Bae, Sunggeun Goo, Jinjong Myoung Journal of Microbiology and Biotechnology.2023; 33(12): 1587. CrossRef
Two years of COVID-19 pandemic: where are we now? Jinjong Myoung Journal of Microbiology.2022; 60(3): 235. CrossRef
Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin Sameer-ul-Salam Mattoo, Seong-Jun Kim, Dae-Gyun Ahn, Jinjong Myoung Viruses.2022; 14(3): 530. CrossRef
Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector Irina Isakova-Sivak, Ekaterina Stepanova, Victoria Matyushenko, Sergei Niskanen, Daria Mezhenskaya, Ekaterina Bazhenova, Elena Krutikova, Tatiana Kotomina, Polina Prokopenko, Bogdan Neterebskii, Aleksandr Doronin, Elena Vinogradova, Kirill Yakovlev, Konst Vaccines.2022; 10(7): 1142. CrossRef
Various pretreatment procedures and selective media were applied to assess the optimal conditions for the isolation of rare actinomycetes from soil. Pretreatment of wet-heating for 15 min at 70oC and phenol treatment of soil suspension were the most effective methods for the isolation of those microorganisms. Hair hydrolysate vitamin agar (HHVA) was the most suitable medium for the recovery of rare actinomycetes. Thirty-five rare actinomycete strains were chosen using selective isolation approaches, then morphological and chemical properties of the isolates were determined. The isolates belonged to one of the following genus, Micromonospora, Microbispora, Actinoplanes and Streptosporangium.